Abstract:Gut microbiota dysbiosis potentially increases the risk of asthma and bronchiolitis in children. Moreover, a deeper understanding of the gut–lung axis with regard to the gut microbiota of children with respiratory diseases could contribute to clinical practice for pulmonary diseases. Introduction Asthma and bronchiolitis in children are considered common clinical problems associated with gut microbiota. However, the exact relationship between gut microbiota and the above‐mentioned diseases remains unclear. Here, we discussed recent advances in understanding the potential mechanism underlying immune regulation of gut microbiota on asthma and bronchiolitis in children as well as the role of the gut–lung axis. Methods We retrieved and assessed all relevant original articles related to gut microbiota, airway inflammation‐induced wheezing in children, and gut–lung axis studies from databases that have been published so far, including PubMed/MEDLINE, Scopus, Google Scholar, China National Knowledge Infrastructure (CNKI) and the Wanfang Database. Results The infant period is critical for the development of gut microbiota, which can be influenced by gestational age, delivery mode, antibiotic exposure and feeding mode. The gut microbiota in children with asthma and bronchiolitis is significantly distinct from those in healthy subjects. Gut microbiota dysbiosis is implicated in asthma and bronchiolitis in children. The presence of intestinal disturbances in lung diseases highlights the importance of the gut–lung axis. Conclusion Gut microbiota dysbiosis potentially increases the risk of asthma and bronchiolitis in children. Moreover, a deeper understanding of the gut–lung axis with regard to the gut microbiota of children with respiratory diseases could contribute to clinical practice for pulmonary diseases.

Gut‐lung axis and asthma: A historical review on mechanism and future perspective

The gut microbiota modulates airway inflammation in allergic asthma through the gut-lung axis related immune modulation: A review

Gut microbiota dysbiosis and its impact on asthma and other lung diseases: potential therapeutic approaches

Cross-domain microbiomes: the interaction of gut, lung and environmental microbiota in asthma pathogenesis

A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases

The role of gut microbiome in the complex relationship between respiratory tract infection and asthma

Gut microecological regulation on bronchiolitis and asthma in children: A review

The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases

COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics

The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches

Gut Mycobiome and Asthma

The Intriguing Connection Between the Gut and Lung Microbiomes

Traditional Chinese medicine to improve immune imbalance of asthma: focus on the adjustment of gut microbiota

Gut-Lung Microbiota in Chronic Pulmonary Diseases: Evolution, Pathogenesis, and Therapeutics

The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections

Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment

Alveolar macrophage modulation via the gut–lung axis in lung diseases

Possible role of gut microbes and host’s immune response in gut–lung homeostasis

Diet, Microbiota and Gut-Lung Connection

Impact of gut microbiota on immune reactions relevant to lung pathologies

Gut microbiota: A new insight into lung diseases